Pueraria Mirifica for Menopausal Symptom Relief and Tissue Support
Jill Stansbury
Paul Saunders
David Winston
PDF
HTML

Keywords

Menopausal symptoms
Pueraria
Selective estrogen receptor modulator
phytoestrogen
PDF
HTML

Abstract

Pueraria Mirifica, a member of the Leguminoseae family, is an herb indigenous to Thailand and has been researched extensively for its beneficial effects in the treatment of menopausal symptoms. Puerarin, the main isoflavone component of Pueraria Mirifica, modulates estrogen receptor expression and could be a safe alternative for the treatment of estrogen dependent conditions. Pueraria also contains the phytoestrogen miroestrol, which functions as a selective estrogen receptor modulator by competitively binding to estrogen and blocking excessive estrogen receptor stimulation. Pueraria root extract has no known side effects and no known drug interactions have been reported. Its beneficial effects on alleviating menopausal symptoms include the reduction of bone loss and hot flashes and the improvement of blood lipid profiles, which could lead to protection from cardiovascular disease. Results of clinical trials have suggested that Pueraria may be a safe alternative to traditional drugs because of its beneficial effects on bone density, genitourinary function and cardiovascular health without the side effects or risks associated with hormone replacement therapy.

PDF
HTML

References

Sugiyama H, Kumamoto T, Suganami A, Nakanishi W, Sowa Y, Takiguchi M, et al. Insight into estrogenicity of phytoestrogens using in silico simulation. Biochem Biophys Res Commun. 2009; 379(1):139–44.
McCabe LD, et al. Antiresorptive effects of phytoestrogen supplements compared with Estradiol or Risedronate in postmenopausal women using (41)Ca methodology. Journal of Clinical Endocrinology & Metabolism. 2009; 94(10):3798–805.
Wattanapitayakul SK, Chularojmontri L, Srichirat S. Effects of Pueraria mirifica on vascular function of ovariectomized rabbits. J Med Assoc Thai. 2005; 88 Suppl 1 S21–9.
Penetar DM, Teter CJ, Ma Z, Tracy M, Lee DY-, Lukas SE. Pharmacokinetic profile of the isoflavone puerarin after acute and repeated administration of a novel kudzu extract to human volunteers. Journal of Alternative and Complementary Medicine. 2006; 12(6):543–8.
Tang X, Zhu X, Liu S, Nicholson RC, Ni X. Phytoestrogens induce differential estrogen receptor beta-mediated responses in transfected MG-63 cells. Endocrine. 2008; 34(1-3):29–35.
Lamlertkittikul S, Chandeying V. Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women : Phase II study. Journal of the Medical Association of Thailand. 2004; 87(1):33–40.
Trisomboon H, Malaivijitnond S, Watanabe G, Cherdshewasart W, Taya K. The estrogenic effect of Pueraria mirifica on gonadotrophin levels in aged monkeys. Endocrine. 2006; 29(1):129–34.
Trisomboon H, Malaivijitnond S, Suzuki J, Hamada Y, Watanabe G, Taya K. Long-term treatment effects of Pueraria mirifica phytoestrogens on parathyroid hormone and calcium levels in aged menopausal cynomolgus monkeys. Journal of Reproduction and Development. 2004; 50(6):639–45.
Wang J, Guo Y, Niu J, Liu J, Wang L, Li P. Effects of Radix Puerariae flavones on liver lipid metabolism in ovariectomized rats. World journal of gastroenterology : WJG. 2004; 10(13):1967–70.
Cherdshewasart W, Subtang S, Dahlan W. Major isoflavonoid contents of the phytoestrogen rich-herb Pueraria mirifica in comparison with Pueraria lobata. J Pharm Biomed Anal. 2007; 43(2):428–34.
Woo J, Lau E, Ho SC, Cheng F, Chan C, Chan ASY, et al. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause-the Journal of the North American Menopause Society. 2003; 10(4):352–61.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women’s Health Initiative randomized controlled trial. Jama-Journal of the American Medical Association. 2002; 288(3):321–33.
Manonai J, Seif C, Boehler G, Juenemann KP. The effect of Pueraria mirifica on cytologic and urodynamic findings in ovariectomized rats. Menopause-the Journal of the North American Menopause Society. 2009; 16(2):350–6.
Manonai J, Chittacharoen A, Theppisai U, Theppisai H. Effect of Pueraria mirifica on vaginal health. Menopause-the Journal of the North American Menopause Society. 2007; 14(5):919–24.
Polotsky HN, Polotsky AJ. Metabolic Implications of Menopause. Semin Reprod Med. 2010; 28(5):426–34.
Agrinier N, Cournot M, Ferrieres J. Dyslipidemia in women after 50: Age, menopause or both? Annales De Cardiologie Et D Angeiologie. 2009; 58(3):159–64.
Ren J, Kelley RO. Cardiac Health in Women With Metabolic Syndrome: Clinical Aspects and Pathophysiology. Obesity. 2009; 17(6):1114–23.
Carlson S, Peng N, Prasain JK, Wyss JM. Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females. Gender Medicine. 2008; 5:S76–S90.
Okamura S, Sawada Y, Satoh T, Sakamoto H, Saito Y, Sumino H, et al. Pueraria Mirifica Phytoestrogens improve Dyslipidemia in Postmenopausal Women Probably by Activating Estrogen Receptor Subtypes. Tohoku J Exp Med. 2008; 216(4):341–51.
Manonai J, Chittacharoen A, Udomsubpayakul U, Theppisai H, Theppisai U. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Menopause-the Journal of the North American Menopause Society. 2008; 15(3):530–5.
Chandeying V, Lamlertkittikul S. Challenges in the conduct of Thai herbal scientific study: Efficacy and safety of phytoestrogen, pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women. Journal of the Medical Association of Thailand. 2007; 90(7):1274–80.
Chandeying V, Sangthawan M. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: Phase III study. Journal of the Medical Association of Thailand. 2007; 90(9):1720–6.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.